BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 8, 2006
View Archived Issues
Drug bioavailability increased by tight junction modulator AT-1002 in preclinical studies
Read More
Enrollment begins in pivotal study of NOV-002 in advanced NSCLC
Read More
Watson completes acquisition of Andrx
Read More
Accentia set to open enrollment in phase III chronic sinusitis study of SinuNase
Read More
Antigen Express' synthetic avian influenza vaccine to begin clinical trials
Read More
Abbott to acquire Kos
Read More
Phase III trials of tramiprosate cleared to continue
Read More
Ziopharm acquires indibulin from Baxter
Read More
Survival data for Erbitux in metastatic colorectal cancer
Read More
Numax achieves primary endpoint in RSV study
Read More
CRx-102 demonstrates positive effect in rheumatoid arthritis
Read More
Bremelanotide effective in diabetic and nondiabetic erectile dysfunction patients
Read More
Positive interim survival results for picoplatin in SCLC
Read More
Celgosivir combination therapy shows benefit in chronic HCV nonresponders
Read More
Enrollment advances in phase III Riquent study
Read More
Long-term efficacy of entecavir in hepatitis B reported
Read More
Respiratory syncytial virus/parainfluenza virus type 3 vaccine safe in phase I study
Read More
Studies assess effects of PF-03491390 in hepatitis C, liver transplantation
Read More
Several new studies of rotigotine presented
Read More
Phase III results show improvements in COPD measures with arformoterol
Read More
Ambrisentan does not interact with warfarin or sildenafil
Read More
BLA filing for Thrombin
Read More
Voraxaze BLA withdrawn, with plans to resubmit
Read More
Duetact now available in U.S.
Read More
orBec filed in Europe for GI GVHD
Read More
Recent Dabur patent describes novel peptide-based therapeutic agents for alopecia
Read More
Recent patents describe new antidiabetic agents
Read More
Recent patents cover new therapeutic agents for cancer
Read More
Positive phase Ib results for AZD-6244 against solid tumors, phase II trials initiated
Read More
Preclinical data on liposomal irinotecan, IHL-305, versus irinotecan
Read More